Journal of The American Society of Nephrology最新文献

筛选
英文 中文
Hypercalcemia's Hidden Regulator: Calcium-Sensing Receptor and the Kidney's Secret Weapon. 高钙血症的隐藏调节剂:钙敏感受体和肾脏的秘密武器。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-15 DOI: 10.1681/asn.0000000725
Jessica Paola Bahena-López,Gerardo Gamba
{"title":"Hypercalcemia's Hidden Regulator: Calcium-Sensing Receptor and the Kidney's Secret Weapon.","authors":"Jessica Paola Bahena-López,Gerardo Gamba","doi":"10.1681/asn.0000000725","DOIUrl":"https://doi.org/10.1681/asn.0000000725","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"42 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144065580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-Based Guidance for Strategies for Blood Transfusion with CKD and Myocardial Infarction. CKD合并心肌梗死患者输血策略的循证指南。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-13 DOI: 10.1681/asn.0000000736
Michelle M Y Wong,Charles A Herzog
{"title":"Evidence-Based Guidance for Strategies for Blood Transfusion with CKD and Myocardial Infarction.","authors":"Michelle M Y Wong,Charles A Herzog","doi":"10.1681/asn.0000000736","DOIUrl":"https://doi.org/10.1681/asn.0000000736","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"35 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143945471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States. Vadadustat在美国国内外治疗ckd相关贫血的安全性和有效性
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-13 DOI: 10.1681/asn.0000000708
Glenn M Chertow,Kai-Uwe Eckardt,Mark J Sarnak,Wolfgang C Winkelmayer,Rajiv Agarwal,Todd Minga,Wenli Luo,Steven K Burke
{"title":"Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States.","authors":"Glenn M Chertow,Kai-Uwe Eckardt,Mark J Sarnak,Wolfgang C Winkelmayer,Rajiv Agarwal,Todd Minga,Wenli Luo,Steven K Burke","doi":"10.1681/asn.0000000708","DOIUrl":"https://doi.org/10.1681/asn.0000000708","url":null,"abstract":"BACKGROUNDVadadustat's global clinical program was comprised of four noninferiority trials comparing vadadustat and darbepoetin alfa for CKD-related anemia: two in dialysis-dependent (DD)-CKD and two in non-dialysis-dependent (NDD)-CKD. While vadadustat met prespecified noninferiority criteria for hematological efficacy globally, it did not meet noninferiority criteria for cardiovascular safety in the NDD-CKD trials. The trials considered regional differences in treatment practices, including hemoglobin targets within (10-11 g/dL) and outside the US (10-12 g/dL).METHODSTo examine region-specific outcomes, we performed prespecified analyses for US and non-US patient subgroups from the vadadustat global program. The primary safety end point was first occurrence of MACE (death from any cause, or nonfatal myocardial infarction or stroke). The primary efficacy end point was change in hemoglobin from baseline to average values during weeks 24-36.RESULTS4084/7399 (55%) randomized patients were enrolled in the US. In pooled analyses of all US patients, MACE risk was similar among vadadustat-treated and darbepoetin alfa-treated patients (hazard ratio [HR] 1.03; 95% CI 0.90-1.17). HRs were similar for US patients with DD-CKD (HR 1.00; 95% CI 0.84-1.18) and NDD-CKD (HR 1.06; 95% CI 0.87-1.29). In pooled analyses of non-US patients, MACE risk was numerically higher among vadadustat-treated patients (HR 1.12; 95% CI 0.94-1.33); the higher risk was primarily attributed to the NDD-CKD subgroup (HR 1.29; 95% CI 1.03-1.60). In the non-US DD-CKD subgroup, MACE risk was similar among vadadustat-treated and darbepoetin alfa-treated patients (HR 0.88; 95% CI 0.67-1.17). Changes in hemoglobin were similar among treatment groups in all regions, as were rates of treatment-emergent and serious adverse events.CONCLUSIONSIn patients with DD-CKD, safety (vis-à-vis MACE) and efficacy (vis-à-vis change in hemoglobin) of vadadustat and darbepoetin alfa were similar when stratified by region (US versus non-US). In US patients with NDD-CKD, safety and efficacy of vadadustat and darbepoetin alfa were similar.","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"32 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143945473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation. 乙酰唑胺和肾血流动力学:肾小管肾小球反馈和肾素-血管紧张素-醛固酮系统适应之间的相互作用。
IF 10.3 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-12 DOI: 10.1681/ASN.0000000731
Hiroki Ito, Takefumi Mori
{"title":"Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation.","authors":"Hiroki Ito, Takefumi Mori","doi":"10.1681/ASN.0000000731","DOIUrl":"10.1681/ASN.0000000731","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":" ","pages":"1450-1451"},"PeriodicalIF":10.3,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Reply: Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation. 作者回复:乙酰唑胺与肾血流动力学:肾小管肾小球反馈与肾素-血管紧张素-醛固酮系统适应之间的相互作用。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-12 DOI: 10.1681/asn.0000000732
Charles Ginsberg,Jeremy Pettus,Joachim H Ix
{"title":"Authors' Reply: Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation.","authors":"Charles Ginsberg,Jeremy Pettus,Joachim H Ix","doi":"10.1681/asn.0000000732","DOIUrl":"https://doi.org/10.1681/asn.0000000732","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"3 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143945127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Reply: Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR. 作者回复:对基于胱抑素C和肌酐的eGFR住院治疗的担忧。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-08 DOI: 10.1681/asn.0000000741
Ian E McCoy,Chi-Yuan Hsu
{"title":"Authors' Reply: Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR.","authors":"Ian E McCoy,Chi-Yuan Hsu","doi":"10.1681/asn.0000000741","DOIUrl":"https://doi.org/10.1681/asn.0000000741","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"39 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143926456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury. 工程神经药物U在急性肾损伤中促进2型先天免疫和肾保护。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-08 DOI: 10.1681/asn.0000000747
Sara Trindade-Correia,Vasco Correia,Filipe Delgado,Marta Baptista,Inês Amendoeira Cabral,Tânia Carvalho,Luana Macedo,Margarida Nunes,Pedro Z Andrade,Filipa Cardoso,Julie Chesné,David F Braga Malta,Covadonga Pañeda,Henrique Veiga-Fernandes,Vânia Cardoso
{"title":"Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury.","authors":"Sara Trindade-Correia,Vasco Correia,Filipe Delgado,Marta Baptista,Inês Amendoeira Cabral,Tânia Carvalho,Luana Macedo,Margarida Nunes,Pedro Z Andrade,Filipa Cardoso,Julie Chesné,David F Braga Malta,Covadonga Pañeda,Henrique Veiga-Fernandes,Vânia Cardoso","doi":"10.1681/asn.0000000747","DOIUrl":"https://doi.org/10.1681/asn.0000000747","url":null,"abstract":"BACKGROUNDAcute kidney injury (AKI) is a severe condition leading to the sudden loss of kidney function. Activation of type 2 innate lymphoid cells (ILC2s) by neuromedin U (NMU) is highly selective and key in controlling mucosal tissue repair and homeostasis. Renal ILC2s are associated with renoprotective effects in AKI. Here, we explored the therapeutic potential of an engineered NMU analogue (LIMM102) in a preclinical model of renal ischemia-reperfusion injury (IRI)-induced AKI.METHODSLIMM102 was administered prophylactically to wild-type (WT) mice subjected to IRI-induced AKI and to sham-operated controls. Survival, glomerular filtration rate (GFR), kidney function biomarkers, histopathological analysis, and immune cell infiltration were assessed to determine LIMM102 treatment efficacy. Moreover, to interrogate the molecular selectivity of LIMM102, NMUR1-deficient mice (Nmur1-/-) were used to formally test the need of NMUR1 signalling for the beneficial effects of LIMM102.RESULTSLIMM102-treated IRI animals presented reduced mortality rates when compared to their untreated IRI counterparts. Notably, LIMM102-treated animals displayed higher GFR, lower levels of kidney function biomarkers, and lower severity of kidney lesions, which associated with renal ILC2-activated phenotypes. Importantly, LIMM102 therapeutic effects relied entirely on NMUR1 signalling, as LIMM102 administration produced no beneficial effect on AKI outcome in Nmur1 deficient animals.CONCLUSIONSLIMM102 exerted its renal therapeutic action by improving kidney function in IRI-induced AKI via NMUR1, which was associated with the presence of activated ILC2s in the kidney.","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"92 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143926457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR. 对基于胱抑素C和肌酐的eGFR住院治疗的关注。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-08 DOI: 10.1681/asn.0000000740
Shiwei Yang,Xianhai Zhao,Linghua Wang,Guang Zhang
{"title":"Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR.","authors":"Shiwei Yang,Xianhai Zhao,Linghua Wang,Guang Zhang","doi":"10.1681/asn.0000000740","DOIUrl":"https://doi.org/10.1681/asn.0000000740","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"19 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143926458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histologic Features Associated with Kidney Survival in Scleroderma Renal Crisis. 硬皮病肾危象患者肾脏存活的组织学特征。
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-07 DOI: 10.1681/asn.0000000720
Yannick Binois,David Buob,Marie-Sophie Meuleman,Idris Boudhabhay,Pierre Isnard,Marion Rabant,Viviane Gnemmi,Laurent Daniel,Isabelle Brocheriou,Clement Gosset,Marie Frimat,Thomas Quémeneur,Rafik Mesbah,Noemie Jourde-Chiche,Olivier Moranne,Pierre Housset,Emmanuel Esteve,Alexis Mathian,Sebastien Rivière,Aurélie Hummel,Luc Mouthon,Benjamin Chaigne,Anne Lyse Langlois,Eric Thervet,Olivier Aubert,Lubka Roumenina,Sophie Chauvet,Alexandre Karras,Jean-Paul Duong-Van-Huyen
{"title":"Histologic Features Associated with Kidney Survival in Scleroderma Renal Crisis.","authors":"Yannick Binois,David Buob,Marie-Sophie Meuleman,Idris Boudhabhay,Pierre Isnard,Marion Rabant,Viviane Gnemmi,Laurent Daniel,Isabelle Brocheriou,Clement Gosset,Marie Frimat,Thomas Quémeneur,Rafik Mesbah,Noemie Jourde-Chiche,Olivier Moranne,Pierre Housset,Emmanuel Esteve,Alexis Mathian,Sebastien Rivière,Aurélie Hummel,Luc Mouthon,Benjamin Chaigne,Anne Lyse Langlois,Eric Thervet,Olivier Aubert,Lubka Roumenina,Sophie Chauvet,Alexandre Karras,Jean-Paul Duong-Van-Huyen","doi":"10.1681/asn.0000000720","DOIUrl":"https://doi.org/10.1681/asn.0000000720","url":null,"abstract":"BACKGROUNDScleroderma renal crisis is a severe complication of systemic sclerosis that is associated with higher morbidity and mortality. However, limited data are currently available regarding the factors affecting renal outcome during scleroderma renal crisis. The objective of this study is to describe renal histopathology in scleroderma renal crisis and to evaluate its association with kidney failure.METHODSWe performed a French multicenter retrospective study that included 65 patients who underwent a kidney biopsy in the context of scleroderma renal crisis, between 2006 and 2020. Non-supervised hierarchical cluster analysis was used to identify histologic patterns. Cox model was performed to estimate the hazard ratios associated with histologic parameters for kidney failure, defined as the need for long-term dialysis therapy of or eGFR <15 ml/min/1.73m2 at last follow-up. Multiplexed sequential Immunofluorescence and proximity ligation assay was used in kidney biopsies to analyze complement system activation.RESULTSRenal pathology in scleroderma renal crisis was more heterogeneous than expected, with 3 histological patterns of kidney injury identified by cluster analysis. Multivariable analysis showed that together with creatinine at presentation, acute arteriolar thrombotic microangiopathy and onion skinning in small arteries were independently associated with the risk of kidney failure. Multiplex immunofluorescence identified fractions from the complement classical pathway in arterioles and arteries in scleroderma renal crisis, while proximity ligation experiments confirmed the in situ activation of classical pathway C3 convertase. Complement terminal pathway fraction C5b-9 was localized in injured arteries.CONCLUSIONSThis study shows that the clinical definition of scleroderma renal crisis encompasses heterogeneity in the patterns of kidney injury. Acute arteriolar thrombotic microangiopathy and onion skinning were associated with kidney failure. Complement system was activated in these injured vessels.","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"26 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143921090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profibrotic Mucosal-Associated Invariant T Cells Were Polarized to Produce IL-17 in Peritoneal Fibrosis: A New Kid on the Block? 纤维化粘膜相关的不变性T细胞在腹膜纤维化中极化产生IL-17:一个新来的孩子?
IF 13.6 1区 医学
Journal of The American Society of Nephrology Pub Date : 2025-05-07 DOI: 10.1681/asn.0000000733
Jing Liu,Simon Davies,Jing O Wu
{"title":"Profibrotic Mucosal-Associated Invariant T Cells Were Polarized to Produce IL-17 in Peritoneal Fibrosis: A New Kid on the Block?","authors":"Jing Liu,Simon Davies,Jing O Wu","doi":"10.1681/asn.0000000733","DOIUrl":"https://doi.org/10.1681/asn.0000000733","url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"48 1","pages":""},"PeriodicalIF":13.6,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143921087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信